Evidence map›Paper›PMID 21637955›Full record

ArticleMolecular biology reports2012

Aldose reductase regulates TNF-α-induced inducible nitric oxide synthase expression in human mesangial cells.

Jingjing Zhao, Tao Jiang, Hui Li, Yuejuan Zhang, Nong Zhang

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Inhibition of ERK1/2 by silymarin in mouse mesangial cells.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jingjing ZhaoDepartment of Pathology, Shanghai Medical School, Fudan University, 138 Yi Xue Yuan Road, Shanghai 200032, China. 072101049@fudan.edu.cn
Tao Jiang
Hui Li
Yuejuan Zhang
Nong Zhang
Shanghai Medical College of Fudan University · CNFudan University · CNYantaishan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glomerulonephritis is one of the most important causes of renal failure, which is accompanied with production of Nitric Oxide (NO) synthesized by inducible nitric oxide synthase (iNOS). Aldose reductase (AR) is the key enzyme in polyol pathway and plays an important role in glucose metabolism. Here, we report our finding that AR regulates tumor-necrosis-factor-α-induced (TNF-α-induced) iNOS expression in human mesangial cells (HMC) via nuclear factor κB (NFκB) signal pathway. The TNF-α-induced iNOS expression in HMC with different level of AR was measured by Real-time PCR and Western blot. The activation of signal pathway was analyzed by Western blot and electrophoretic mobility shift assay (EMSA). In cultured HMC, TNF-α induces the expression of iNOS, which is attenuated by knockdown AR with siRNA. On the other side, transfection with pcDNA3.1-AR gets the consistent conclusion. Furthermore, knockdown of AR attenuated activity of NFκB, suggesting that the effects of AR on this pathway may result in the reduced iNOS transcription and expression. Taken together, these data demonstrate the role of AR in regulating iNOS expression induced by TNF-α in cultured HMC, indicating the novel function of AR in glomerulonephritis besides glucose metabolism.

Indexed as

Aldehyde ReductaseBlotting, WesternCells, CulturedElectrophoretic Mobility Shift AssayGene Expression Regulation, EnzymologicGlomerulonephritisHumansMesangial CellsNF-kappa BNitric Oxide Synthase Type IIReal-Time Polymerase Chain ReactionRNA, Small InterferingTumor Necrosis Factor-alphaAldehyde ReductaseNF-kappa BNitric Oxide Synthase Type IIRNA, Small InterferingTumor Necrosis Factor-alpha

Identifiers

PMID21637955
OpenAlexW2065472888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.